5439042026-05-195439042026-05-192026-05-195439042026-05-19in-capmkt:FinancialYear1Member5439042026-05-19in-capmkt:FinancialYear2Member5439042026-05-19in-capmkt:FinancialYear3Member5439042026-05-192026-05-19in-capmkt:FinancialYear1Member5439042026-05-192026-05-19in-capmkt:FinancialYear2Member5439042026-05-192026-05-19in-capmkt:FinancialYear3Memberiso4217:INRxbrli:pure543904Mankind Pharma LimitedMANKINDNOTLISTEDINE634S01028NewAcquisition (including agreement to acquire)true2026-05-1916:30:002026-05-19The Board of Directors of the Company, in its meeting held on May 19, 2026, has considered and approved the additional investment of up to Rs.500 crores in Mankind Medicare Private Limited, a wholly owned subsidiary, in one or more tranches; Mankind Pharma LimitedListed Entity (self)Mankind Medicare Private Limited320000088000001489600000true2026-05-19falsefalsetruePharmaceutical IndustryFunds will be utilized for capacity expansion and plant being set-up.NAtrueNACash5000000000Investment of up to ₹500 crores, by way of subscription to securities of Medicare, in one or more tranches, on such terms and conditions as may be mutually agreed between the companies.5000000000111Medicare is an existing wholly owned subsidiary company, incorporated in India on September 12, 2023, engaged in the business of manufacturing and production of various types of pharmaceutical products.2023-09-122025-202632000002024-20252000002023-20240India